Organizer: World Parkinson Congress (WPC)
Website: [worldparkinsoncongress.org](https://www.worldparkinsoncongress.org)
Timing: Every 3 years
Overview
Mermaid diagram (expand to render)
The World Parkinson Congress (WPC) is the premier international meeting dedicated exclusively to [Parkinson's disease](/diseases/parkinsons-disease) and related disorders including [multiple system atrophy](/diseases/multiple-system-atrophy), [progressive supranuclear palsy](/diseases/progressive-supranuclear-palsy), and [dementia with Lewy bodies](/diseases/dementia-lewy-bodies). Unlike general neurology conferences, WPC focuses specifically on Parkinson's, bringing together the entire Parkinson's community including researchers, clinicians, people with Parkinson's, care partners, and advocates["@world"].
The triennial congress provides a unique platform for knowledge exchange, collaboration, and advocacy, with a distinctive emphasis on including people living with Parkinson's as active participants rather than merely observers. This patient-inclusive approach has helped shape research priorities and clinical care practices["@bloem2023"].
Conference Characteristics
Unique Features
Triennial Schedule: Held every three years (2026 will be 7th WPC)
Patient Inclusion: People with Parkinson's actively participate as presenters and leaders
Global Reach: Delegates from 70+ countries worldwide
Comprehensive Focus: All aspects of Parkinson's care and research
Attendance Profile
3,000+ healthcare professionals
1,000+ people with Parkinson's
500+ care partners and family members
300+ researchers and clinicians
200+ industry representatives
Scientific Program
Research Tracks
Basic Science
[Alpha-synuclein](/proteins/alpha-synuclein) biology and [aggregation mechanisms](/mechanisms/alpha-synuclein-aggregation)
[Mitochondrial dysfunction](/mechanisms/mitochondrial-dysfunction-pd) in PD pathogenesis
[Neuroinflammation](/mechanisms/neuroinflammation-pd) and [immune responses](/mechanisms/neuroinflammation-immune-response)
[Genetic factors](/diseases/parkinsons-disease-genetics) in Parkinson's including [LRRK2](/genes/lrrk2), [GBA](/genes/gba), [SNCA](/genes/snca), and [PARKIN](/genes/parkin)
[Protein homeostasis](/mechanisms/protein-homeostasis-disruption) and [autophagy pathways](/mechanisms/autophagy-lysosomal-pathway)
Clinical Research
[Clinical trials](/clinical-trials) and [novel therapeutics](/therapeutics/parkinsons-disease-drug-pipeline)
[Biomarker](/biomarkers) development and validation